Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics and bioavailability of a new long-acting insulin analog in healthy Chinese volunteers: an open, randomized, single-dose, two-period and two-sequence cross-over study.
Chen KG, Zhang YH, Ye PP, Gao XH, Song LL, Zhou HY, Li Q, Zhao FR, Shi JY, Yang XM, Shen K, Feng S, Zhao W. Chen KG, et al. Among authors: shen k. Front Pharmacol. 2023 Dec 22;14:1294810. doi: 10.3389/fphar.2023.1294810. eCollection 2023. Front Pharmacol. 2023. PMID: 38186641 Free PMC article.
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study.
Yang L, Fang Y, Luo Y, Fu M, Shen K, Luo Z. Yang L, et al. Among authors: shen k. Expert Opin Investig Drugs. 2024 Jun 3:1-12. doi: 10.1080/13543784.2024.2361065. Online ahead of print. Expert Opin Investig Drugs. 2024. PMID: 38805242
Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial.
Dai Z, Zhu R, Sheng Z, Qin G, Luo X, Qin Q, Song C, Li L, Jin P, Yang G, Cheng Y, Peng D, Zou C, Wang L, Shentu J, Zhang Q, Zhang Z, Yan X, Fang P, Yan Q, Yang L, Fan X, Liu W, Wu B, Cui R, Wu X, Xie Y, Shu C, Shen K, Wei W, Lu W, Chen H, Zhou Z. Dai Z, et al. Among authors: shen k. Front Endocrinol (Lausanne). 2023 Apr 5;14:1168757. doi: 10.3389/fendo.2023.1168757. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37091850 Free PMC article. Clinical Trial.
3,367 results